Biotech News
Erasca Announces Pricing of Upsized Public Offering of Common Stock
investors.erasca.com2026-05-06 14:59 EST
SAN DIEGO , Jan. 21, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an upsized public